RiboDynamics

RiboDynamics is a private early-stage life sciences company developing nucleic-acid analysis and diagnostic technologies based on RNA biomarkers and mass spectrometric data interpretation. The company appears to have originated from academic work led by Dan Fabris and has been described as a UConn-affiliated startup and as RiboDynamics LLC in Albany, New York. Its technology has been presented both as a software platform for interpreting canonical and non-canonical nucleotide mass mapping and sequencing data and as a medical technology intended to accelerate pathogen detection in biological samples. Public descriptions suggest applications in rapid infectious disease diagnosis, including sepsis, as well as contamination testing in milk. The company appears to be platform-oriented rather than a therapeutics developer, with no clear evidence of clinical-stage drug candidates or marketed products.